Cyclin-dependent kinases (Cdks) control major transitions as cells pass through the cell cycle. It has recently been shown that centrosome duplication in vertebrates requires Cdk2 activity and can be driven solely by Cdk2-cyclin E complexes.
Two precise duplication events occur each and every eukaryotic cell cycle; one is the replication of chromosomal DNA and the other is duplication of the centrosome or the equivalent organelle that will function as the spindle pole (see [1] for a recent review of centrosomes). The mitotic spindle is organized, in large part, by the two centrosomes resulting from the duplication event. The spindle captures the chromosomes and ultimately serves to segregate one set of chromosomes and one centrosome to each progeny cell. After the cell passes the restriction point, or 'Start', and commits to the cell cycle, correct execution of these duplication and segregation events are the most critical functions in the cell cycle.
The central importance of DNA replication and centrosome duplication is apparent from the various 'checkpoints' committed to determining whether these events occur and are coordinated correctly [2, 3] . Furthermore, defects in centrosome duplication or function have been observed in some types of transformed cell and are apparent in cells derived from mice lacking the tumor suppressor genes p53 or BRCA1 [4, 5] . It is clear that the control and execution of centrosome duplication is not only a long-standing fundamental question in cell biology, but is also critical to understanding cellular transformation.
Despite the critically important nature of centrosome duplication, even basic points about how the process is controlled in vertebrates have been a mystery. A recent trilogy of papers has revealed an important clue about centrosome duplication, showing that duplication requires cyclin-dependent kinase (Cdk2) activity, and can be specifically driven by Cdk2-cyclin E complexes [6] [7] [8] (Figure 1 ). Cdk-cyclin complexes are well known to drive major transitions in the cell cycle, including the G1-S transition and the onset of anaphase. An important aspect of the newly reported work is that different cell types, both in vivo and in vitro experiments, and a variety of reagents are used to build a convincing case that Cdk2-cyclin complexes drive centrosome duplication.
Interestingly, all three studies capitalized on previous work with Xenopus eggs [9] , sea urchin zygotes [10] and CHO cells [11] which had established conditions leading to continued centrosome duplication during cell-cycle arrest in S phase. This result can be obtained by treating Xenopus eggs with the protein-synthesis inhibitor cycloheximide; as this treatment blocks the synthesis of cyclins A and B, complexes containing these cyclins are ruled out as the driving force behind centrosome duplication. Similarly, hydroxyurea inhibition of DNA synthesis in CHO cells results in accumulation of centrosomes in the absence of cell-cycle progression, but no conclusion can be drawn concerning which cyclins are required for the duplication. But making the assumption that the continued rounds of the centrosome duplication observed in these various experiments are regulated by normal mechanisms, all three groups [6] [7] [8] pursued the regulation of the centrosome reduplication in these systems.
Lacey et al. [6] approached the problem in two ways. The first was to recapitulate the previous observation that cycloheximide-treated Xenopus eggs undergo centrosome reduplication. Having done this, they looked for conditions that would block centrosome duplication, and found that the injection of p21, a small protein inhibitor of Cdk2-cyclin A or Cdk2-cyclin E complexes, or injection of the related p27 inhibitor, blocked centrosome duplication. Furthermore, they demonstrated the specific requirement for Cdk2-cyclin A or Cdk2-cyclin E by coinjecting Cdk2-cyclin E complexes (the major source of Cdk2 activity in these arrested cells) with the inhibitor. They found that centrosome duplication was restored, showing that Cdk2-cyclin E can drive centrosome duplication in vivo.
Similarly, Matsumoto et al. [8] documented centrosome reduplication in hydroxyurea-arrested CHO cells, and found that p21 overexpression blocked the accumulation of centrosomes. The requirement for Cdk2 activity in centrosome reduplication was confirmed using smallmolecule inhibitors of the kinase, and by treatment with mimosine, which arrests cells in late G1 phase and blocks centrosome reduplication. They showed that inhibition of Cdk2 activity was responsible for the block by restoring centrosome duplication in mimosine-treated cells by overexpression of Cdk2. All-in-all, these authors have provided important additional data from a different in vivo system. The second approach taken by Lacey et al. [6] was to develop an in vitro system for studying centriole separation, an early step in centrosome duplication. This system involves seeding extracts from cycloheximide-treated Xenopus zygotes with centrosomes from Xenopus XTC cells, and determining whether centriole pairs resolve into singlets by staining for α tubulin, a marker for centrioles. The separation event requires the activity of the Cdk2 kinase, and as in their in vivo experiments, p21 inhibited separation. Furthermore, depletion of Cdk activity with p13 suc1 beads, which are not specific for a given cyclin type, could inhibit the separation. This inhibition could be overcome by addition of recombinant Cdk2-cyclin E complexes. Specific depletion of either Cdk2-cyclin E or Cdk2-cyclin A complexes did not inhibit centriole separation, but depletion of both did inhibit centriole separation, indicating that cyclin A and cyclin E are redundant for this particular activity or source of centrosomes; in line with this conclusion, addition of just Cdk2-cyclin E restored centriole separation. This result shows that Cdk2-cyclin E is sufficient for centriole separation, but does not indicate if either cyclin is sufficient to drive a full round of centrosome duplication.
These in vivo systems are mimicked by the in vitro system reported by Hinchcliffe et al. [7] , in which multiple rounds of centrosome duplication occur. In their system, cycling Xenopus egg extracts that have been arrested in S phase with aphidicolin are seeded with demembranated sperm nuclei. The sperm nuclei also supply basal bodies, which are converted to centrosomes and then undergo reduplication, as determined by time-lapse video microscopy. Hinchcliffe et al. [7] used a different Cdk inhibitor than the other two groups -a modified form of the Xenopus Cdk inhibitor, ∆34Xic1. Unlike p21, this inhibitor is specific for Cdk2-cyclin E complexes, and its inhibition of centrosome reduplication was shown to be overcome by the addition of exogenous Cdk2-cyclin E complexes, while the extracts are still arrested in S phase. This result indicates that Cdk2-cyclin E complexes can drive a complete round of centrosome duplication. Finally, these authors also showed that cyclin E is localized to centrosomes in Xenopus blastomeres, suggesting that Cdk2-cyclin E complexes might interact directly with centrosome components.
These results raise questions about the nature of the continued rounds of centrosome duplication in the various systems that were used. It is clear that S phase is permissive for continued rounds of centrosome duplication. It is assumed that the centrosome reduplication in these systems is controlled as it is in normal cell cycles. Lacey et al. [6] suggest that embryonic systems are not subject to the "once-and-only-once rule", and that centrosome duplication is inhibited during mitosis to block over-replication. They obtained evidence with their in vitro system that mitotic extracts cannot support centriole separation. Similarly, sea urchin zygotes arrested in mitosis -unlike those arrested in S phase -do not exhibit centrosome reduplication [10] . Embryonic systems may control centrosome duplication by R450 Current Biology, Vol 9 No 12
Figure 1
Studies using centrosome reduplication systems have recently provided evidence that Cdk2-cyclin E is necessary for centrosome duplication [6] [7] [8] . (See text for details.)
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Centriole oscillating between duplication-permissive and duplicationnonpermissive states, the permissive period normally being too short for additional rounds of duplication.
Interestingly, Hinchcliffe et al. [7] were unable to block the first round of in vitro centrosome duplication by depleting their system of Cdk2-cyclin E complexes, though they could effectively block the second and later rounds of duplication. They suggest that the centrosome reduplication systems include a 'licensing' event, so that centrosomes are 'marked' as being capable of duplication [7, 10] . They propose that Cdk2-cyclin E may be the licensing factor, and that the centrosomes in their assay are licensed to duplicate at the outset. The pre-existing centrosomes at the outset of the experiment thus duplicate, but then cannot be relicensed for continued rounds of duplication without Cdk2-cyclin E activity. These initial centrosomes arise, however, from the sperm basal bodies, and may be subject to different rules for duplication [7, 12] . Nonetheless, accepting the notion that centrosome duplication does involve a licensing event, it will be interesting to determine its molecular nature and its mode of regulation in both embryonic and somatic cell cycles.
Although the centrosome reduplication systems used in these various experiments may appear a bit odd, their use clearly indicates that Cdk2-cyclin E complexes have an important and central role in centrosome duplication ( Figure 2 ). Furthermore, these systems are likely to be important in delineating the regulation and execution of centrosome duplication. But how general are the results? The duplication of the yeast equivalent of the centrosome, the spindle pole body, is under the control of different Cdk-cyclin complexes. In budding yeast, spindle pole body duplication can be accomplished by Cdc28 (its Cdk) in a complex with the G1 cyclins, the Clns [13] . Fission yeast cells do not even duplicate their spindle pole bodies until G2 [14] , when the duplication is presumably under the control of Cdc2 (its Cdk) in a complex with the mitotic cyclin Cdc13. It may not be surprising that spindle pole duplication is driven by different Cdk-cyclin complexes in different cell types, given their different lifestyles, but the observation does raise some questions.
It will be interesting to learn more about the signaling pathway between Cdk-cyclin complexes and the centrosome assembly machinery. While the initiation of DNA synthesis involves a number of conserved componentsthe MCM proteins, the origin-recognition complex (ORC) and Cdk2-cyclin E [15] -it remains to be seen whether the control of centrosome duplication is similarly conserved. Studies of yeast spindle pole bodies and of Dispatch R451
Figure 2
Spindle pole duplication in various organisms and the dependency of these duplication events on various cyclin-dependent kinases.
(a) The vertebrate centrosome under the control of Cdk2-cyclin E [6] [7] [8] . (b) The budding yeast spindle pole body under the control of Cdc28-Clns [13] . (c) The fission yeast spindle pole body duplication [14] under, it is presumed, the control of the Cdc2-Cdc13. 
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centrosomes in several cell types have identified several centrosomal components, such as γ tubulin, that are clearly conserved, and a few candidate centrosome duplication regulatory genes that may be conserved. We can now look at these molecules involved in centrosome duplication in the context of their response to changes in Cdk2-cyclin E activity, in hope of completing the circuit that connects central cell-cycle control to one of its most important events -centrosome duplication.
